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We show that tyrosine phosphorylation, produced by
incubation of normal human keratinocytes with the
tyrosine phosphatase inhibitor peroxovanadate,
directly and reversibly regulates the association of
b-catenin and plakoglobin with E-cadherin and
a-catenin. Prior studies have demonstrated a correla-
tive, but not causal, association between increased
tyrosine phosphorylation and decreased adherens
junction mediated cell-cell adhesion. We observed
that (i) binding of tyrosine phosphorylated b-catenin
and plakoglobin to E-cadherin and to a-catenin was
substantially reduced, but could be restored in vitro
by removal of phosphate from b-catenin and plako-
globin with added tyrosine phosphatase, and (ii)
tyrosine phosphorylation of b-catenin and plako-
globin was associated with decreased cell±cell
adhesion. These ®ndings support a direct and causal
role for tyrosine phosphorylation of b-catenin and
plakoglobin in regulating adherens junction mediated
cell±cell adhesion. We propose that tyrosine phos-
phorylation of speci®c and probably different
residues is responsible for regulating the binding of
b-catenin or plakoglobin to (i) E-cadherin and (ii)
a-catenin. Additionally, because b-catenin and
plakoglobin have both structural and regulatory
functions, the data raise the possibility that b-catenin
or plakoglobin released from the adherens junctions
by tyrosine phosphorylation may transduce a signal
to the nucleus regarding the adhesive state of the
cell. Key words: adherens junction/adhesion/keratinocyte. J
Invest Dermatol 117:1059±1067, 2001
I
n the skin, keratinocytes migrate from the basal layer
upward to the topmost layer, the stratum corneum,
undergoing a morphologically well-described pattern of
differentiation. This migration can take from 4 wk in
normal tissues to as little as 4 d in in¯ammatory hyperplastic
conditions such as psoriasis (Van Scott and Ekel, 1963; Weinstein
and Van Scott, 1965). Despite this constant state of movement, the
tissue maintains its structural integrity, presumably due to the ability
of adjacent keratinocytes to break and reform their adhesive
contacts with each other in a controlled fashion.
In keratinocytes, adherens junctions are composed of cadherin
(Takeichi, 1988; 1991), b-catenin or plakoglobin, and a-catenin
(Ozawa et al, 1989; Nagafuchi et al, 1991; Butz and Kemler, 1994).
b-Catenin or plakoglobin bind to the cytoplasmic tail of E-
cadherin and to a-catenin (Aberle et al, 1994; Hulsken et al, 1994).
a-Catenin in turn binds to the actin cytoskeleton (Ozawa et al,
1990; Rimm et al, 1995). This assemblage, by forming a continuous
macromolecular complex between the external cell±cell contacts
and the internal actin cytoskeleton, functions to maintain both cell±
cell adhesion and tissue integrity. b-Catenin and plakoglobin
represent potential candidates for the dynamic regulation of
keratinocyte cell±cell adhesion. They have a central role in forming
two key structures that link adjacent keratinocytes, the adherens
junction and the desmosome. Additionally, they have been shown
to participate in Wnt-mediated signal transduction (Funayama et al,
1995; Karnovsky and Klymkowsky, 1995; Miller and Moon, 1996).
Thus, they may provide a link between the sensing of cell±cell
adhesion or the disruption of cell±cell adhesion, and subsequent cell
fate/epithelial differentiation events that occur as a consequence of,
or are directed by, the presence or absence of cell±cell adhesion.
For example, the principle of contact inhibition of cell growth
presumably requires signaling from the cell surface to the nucleus to
alter the pattern of gene transcription from active growth/cell
division to quiescence.
Human b-catenin and plakoglobin are homologs of the
Drosophila melanogaster protein Armadillo, to which they are
structurally and functionally similar (Peifer and Wieschaus, 1990;
Peifer et al, 1992). During their function in the two core processes
of cell±cell adhesion and signal transduction, b-catenin, plakoglo-
bin, and Armadillo interact with a large number of proteins
including: (i) the adherens junction proteins E-cadherin and a-
catenin (Aberle et al, 1994), (ii) the Cdc42 and Rac1 effector
protein IQGAP1 (Fukata et al, 1999), (iii) the actin bundling
protein fascin (Tao et al, 1996), (iv) the transcription factors T cell
factor (TCF) (Molenaar et al, 1996) and lymphoid enhancing factor
(LEF) (Behrens et al, 1996; Huber et al, 1996), (v) the nuclear
protein Pontin 52 (Bauer et al, 1998a), (vi) the tumor suppressor
protein adenomatous polyposis coli (APC) (Rubinfeld et al, 1993;
1995), (vii) presenilins (Zhou et al, 1997; Yu et al, 1998; Zhang et
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al, 1998), (viii) serine/threonine speci®c protein kinases (glycogen
synthase kinase-3), (ix) the epidermal growth factor (EGF)
(Hoschuetzky et al, 1994) and c-erbB-2 (Kanai et al, 1995) receptor
tyrosine kinases, and (x) axin (Kodama et al, 1999) and conductin
(Behrens et al, 1998).
Post-translational modi®cation of b-catenin and plakoglobin
represents a potential mechanism by which these various protein±
protein interactions are regulated. b-Catenin, plakoglobin, and
Drosophila Armadillo are phosphoproteins that contain potential
serine, threonine, and tyrosine phosphorylation sites. Increased
tyrosine kinase activity is associated with decreased cell±cell
adhesion (Matsuyoshi et al, 1992; Behrens et al, 1993; Hamaguchi
et al, 1993; Soler et al, 1998). This decreased cell±cell adhesion may
be due in part to alterations in the adherens junction (Volberg et al,
1991; 1992). Increased tyrosine phosphorylation of E-cadherin, b-
catenin, and plakoglobin was observed when leukemic cells
transfected with an E-cadherin construct were treated with the
tyrosine phosphatase inhibitor peroxovanadate. This was associated
with decreased cell±cell adhesion and dissociation of a-catenin
from the E-cadherin±b-catenin and E-cadherin±plakoglobin com-
plexes (Ozawa and Kemler, 1998). Decreased binding to E-
cadherin of in vitro pp60 c-src tyrosine phosphorylated b-catenin
has recently been reported (Roura et al, 1999). In contrast, recent
work has suggested that tyrosine phosphorylation is associated with
increased stability of adherens junction protein association/binding
and increased cell±cell adhesion in murine keratinocytes (Calautti et
al, 1998).
Because of our interest in understanding how keratinocyte cell±
cell adhesion is regulated and because of the apparent con¯icting
reports regarding the effect of tyrosine phosphorylation on cell±cell
adhesion and the adherens junction, we sought to investigate the
regulation of cell±cell adhesion in a normal human keratinocyte
tissue culture system. These nonimmortalized primary cells may
more closely approximate the in vivo biology than the immortalized
cell lines used in most prior studies. Here we report that (i) tyrosine
phosphorylation of the adherens junction components b-catenin
and plakoglobin causes them to dissociate from E-cadherin and a-
catenin, (ii) this dissociation correlates with decreased keratinocyte
cell±cell adhesion, and (iii) in vitro tyrosine dephosphorylation of b-
catenin and plakoglobin results in the reassociation of b-catenin and
plakoglobin with E-cadherin and a-catenin. Prior studies have
demonstrated associative, but not causal, links between tyrosine
phosphorylation and adherens junction protein association. In this
report, we demonstrate that the effect of tyrosine phosphorylation
on the adherens junction is reversible, providing support for such a
causal link. These in vitro reconstitution experiments are consistent
with a mechanism by which tyrosine phosphorylation of b-catenin
and plakoglobin reversibly regulates the association of adherens
junction protein components. Thus, tyrosine phosphorylation of b-
catenin and plakoglobin probably represents one aspect of the
dynamic regulation of keratinocyte cell±cell adhesion.
MATERIALS AND METHODS
Materials Monoclonal antibodies to human b-catenin and
plakoglobin (N-terminal), a horseradish peroxidase conjugated
monoclonal antiphosphotyrosine antibody (RC20-HRPO conjugate), a
polyclonal rabbit antihuman a-catenin antibody, and protein G sepharose
beads were from Zymed (San Francisco, CA). Monoclonal antibodies to
human E-cadherin and a C-terminal monoclonal antibody to human
plakoglobin were from Transduction Laboratories (Lexington, KY). For
Western blot detection, secondary goat antimouse and goat antirabbit
horseradish peroxidase conjugated IgG and enhanced chemiluminescence
reagents were from Amersham Pharmacia Biotech (Buckinghamshire,
U.K.). For immuno¯uorescent staining, secondary ¯uorescein
isothiocyanate (FITC) and rhodamine conjugated goat antimouse/rabbit
IgG was from Jackson ImmunoResearch Laboratories (West Grove, PA).
Recombinant Yersinia enterocoltica protein tyrosine phosphatase (PTP) was
from Roche-Boehringer Mannheim (Indianapolis, IN). Electrophoresis
reagents were from Bio-Rad (Hercules, CA). All other reagents were of
standard grade from Sigma (St. Louis, MO).
Tissue culture Primary human keratinocytes established from human
neonatal foreskins were obtained from Cascade Biologics (Portland, OR)
and cultured according to the recommended procedure using NHK 154
medium (0.2 mM CaCl2) supplemented with human keratinocyte
growth supplement (Cascade Biologics) and penicillin, streptomycin, and
amphotericin B (Cascade Biologics) according to the manufacturer's
recommendations. Cells were expanded for two passages and third
passage keratinocytes were used for all experiments. For immunopre-
cipitation (IP) experiments, cultures were grown on Falcon
100 3 20 mm polystyrene Petri dishes to 70%±80% con¯uence. Cells
were treated with or without peroxovanadate (0.5 mM Na3VO4, 3 mM
H2O2) for 0±60 min prior to harvesting.
Confocal immuno¯uorescent microscopy For immuno¯uorescent
staining, normal human keratinocytes were grown on ethanol sterilized
glass coverslips. Cells were treated with or without peroxovanadate
(0.5 mM Na3VO4, 3 mM H2O2) for 0±60 min prior to ®xation in 3.7%
paraformaldehyde in Dulbecco's phosphate-buffered saline (DPBS:
137 mM NaCl, 2.7 mM KCl, 0.5 mM MgCl2, 1.5 mM KH2PO4,
6.5 mM Na2HPO4, 0.9 mM CaCl2) for 5 min at room temperature,
permeabilized with 0.25% Trition X-100 in DPBS for 10 min at room
temperature, and blocked with 2% bovine serum albumin (BSA) in
DPBS for 15 min at room temperature. Fixed cells were incubated with
primary antibody overnight at 4°C in a humidity chamber. Each primary
antibody (E-cadherin, a-catenin, b-catenin, and plakoglobin) was diluted
1:100 in antibody dilution buffer (2% BSA, 0.01% Tween 20, 0.1%
NaN3, in DPBS). After overnight incubations with primary antibody,
the coverslip ®xed cells were washed three times for 10 min each in
DPBS at 4°C, blocked with 2% BSA in DPBS at 4°C for 20 min,
incubated with FITC or rhodamine conjugated goat antimouse or goat
antirabbit IgG secondary antibodies diluted 1:100 in antibody dilution
buffer for 90 min at 4°C in the dark, washed three times for 10 min
each in DPBS at 4°C, and then mounted with polyvinyl alcohol
mounting medium [10% (wt/vol) polyvinyl alcohol, 25% (vol/vol)
glycerol, 50 mM Tris-Cl, pH 8.5]. Images were obtained using a Zeiss
laser scanning confocal microscope. For double-labeled images, data from
the two channels were superimposed using LSM 3.8 software, with the
FITC channel in green and the rhodamine channel in red as described
by Loureiro and Peifer (1998).
IP Cell extracts were prepared from normal human keratinocytes in
tissue culture at 70%±80% con¯uence. Each plate (100 3 20 mm) of
cells was harvested on ice in 1 ml lysis buffer [1% Nonidet P-40,
150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1 mM ethyleneglycol-bis(b-
aminoethyl ether)-N,N,N¢,N¢-tetraacetic acid, 1 mM NaF, 10 mM E-64,
100 mM leupeptin, 10 mM pepstatin, and 1 mM phenylmethylsulfonyl
¯uoride], with or without peroxovanadate (1 mM Na3VO4, 3 mM
H2O2). All subsequent steps were done at 4°C. Insoluble material was
removed by high-speed centrifugation. Protein concentration in extracts
was determined by Bradford assay (Bio-Rad, Laboratories, Hercules,
CA). Detergent soluble extracts were subjected to IP with the following
primary antibodies at the indicated concentrations: E-cadherin (3 mg per
ml), a-catenin (3 mg per ml), b-catenin (3 mg per ml), C-terminal
plakoglobin (3 mg per ml). A 50% slurry of protein G beads was then
added to the extract (1:10 vol/vol) and incubated overnight at 4°C with
gentle rotation. The beads were then pelleted in a microfuge for 15 s
and each washed three times with a 65-fold volume excess of lysis
buffer. Samples were eluted from the beads by boiling 15 ml beads in
15 ml sodim dodecyl sulfate (SDS) Laemmli sample buffer containing b-
mercaptoethanol for 3 min. Typically, 5 ml of sample was loaded per
lane and separated by 10% SDS polyacrylamide gel electrophoresis
(PAGE) (Laemmli, 1970) followed by electrotransfer to nitrocellulose
according to established procedures. Nitrocellulose membranes were then
blocked with 3% BSA in TBST (20 mM Tris-HCl, pH 7.6, 137 mM
NaCl, 0.1% Tween 20) and probed for 1 h at room temperature with
primary antibody diluted to the manufacturer's recommendations in
TBST (b-catenin, 1:1000; N-terminal plakoglobin, 1:1000;
antiphosphotyrosine, 1:2500; a-catenin, 1:1000; E-cadherin, 1:2500; C-
terminal plakoglobin, 1:2000). Blots were then washed three times in
TBST and incubated with horseradish peroxidase conjugated secondary
antibody diluted 1:10,000 in TBST, washed three times in TBST, and
developed with enhanced chemiluminescence reagents. Horseradish
peroxidase conjugated antiphosphotyrosine antibodies were developed
directly.
Tyrosine phosphatase activity Measurement of tyrosine phosphatase
activity in keratinocyte cell extracts was based on the molybdate±malac
green±phosphate complex formed with released free phosphate utilizing
the tyrosine phosphatase assay system from Promega (Madison, WI) used
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according to the manufacturer's recommendations. Endogenous free
phosphate in the extracts was removed prior to assay by gel ®ltration
chromatography on Sephadex G-25 spin columns. Levels of released free
phosphate were determined after 30 min incubations at 37°C.
Reconstitution experiments Immunoprecipitates from peroxo-
vanadate-treated cells were split into equal samples. One half was washed
three times with lysis buffer (peroxovanadate free) to remove
peroxovanadate, and then incubated with Yersinia enterocoltica PTP
[25 mU per ml in 20 mM Tris-Cl, pH 7.2, 150 mM NaCl, 0.1 mg per
ml BSA, and 0.1% (vol/vol) 2-mercaptoethanol], in a total volume of
50 ml for 15 ml beads, for 30 min at 37°C; the other half underwent
mock incubation with PTP buffer, but no added PTP. The beads were
then washed three times in lysis buffer. PTP-treated and mock-incubated
proteins were incubated for 2 h at 4°C with gentle rotation with fresh
keratinocyte cell lysates from either control or peroxovanadate-treated
cells, respectively. Protein G beads were then collected and washed three
times with lysis buffer, and the samples were eluted from the beads by
boiling in reducing SDS Laemmli sample buffer. Samples were separated
by 10% SDS-PAGE, followed by electrotransfer to nitrocellulose, and
probed with antibodies to E-cadherin, a-catenin, b-catenin, plakoglobin,
and phosphotyrosine as described above.
To demonstrate that the conditions used for IP resulted in saturation
of protein G bound antibody by antigen (E-cadherin, a-catenin, b-
catenin, or plakoglobin), immune complexes generated from IP of
keratinocyte extracts using monoclonal antibodies to each adherens
junction component (E-cadherin, a-catenin, b-catenin, or plakoglobin)
were split into equal fractions. One half of each IP reaction was then re-
incubated with fresh keratinocyte extracts under conditions used for the
reconstitution experiments, separated by SDS-PAGE, and analyzed by
Western blot detection using the respective antibody. No additional E-
cadherin, a-catenin, b-catenin, or plakoglobin could be detected after
re-incubation of IPs with fresh extract, indicating that the conditions
used for the initial IP were saturating. Additionally, to demonstrate that
antigen in the added back extracts was not displacing bound antigen in
the initial IP reactions, b-catenin and plakoglobin immune complexes
from nonperoxovanadate treated-keratinocytes were split into equal
fractions. One half of each IP reaction was then re-incubated with fresh
extracts from peroxovanadate-treated keratinocytes under conditions used
for the reconstitution experiments. Reactions were separated by SDS-
PAGE and analyzed by Western blot detection using b-catenin or
plakoglobin antibody. Bands of retarded migration corresponding to
tyrosine phosphorylated b-catenin and plakoglobin were not observed
when immune complexes containing nontyrosine phosphorylated b-
catenin and plakoglobin were re-incubated with extracts from peroxova-
nadate-treated cells, indicating that the tyrosine phosphorylated b-catenin
and plakoglobin in the peroxovanadate-treated extracts was not displacing
bound nontyrosine phosphorylated b-catenin and plakoglobin from the
protein G localized antibody.
RESULTS
Cell±cell adhesion is disrupted and adherens junction
protein distribution is altered in peroxovanadate-treated
normal human keratinocytes Exposure of cells in culture to
peroxovanadate, a potent inhibitor of tyrosine phosphatases, results
in a rapid increase in tyrosine phosphorylation of cellular proteins
(Kadota et al, 1987; Ruff et al, 1997). We used peroxovanadate to
investigate the effect of tyrosine phosphorylation on keratinocyte
cell±cell junctions. Keratinocytes, 70%±80% con¯uent, were
exposed to peroxovanadate. Addition of this reagent to the
culture medium disrupted cell±cell adhesion; cell membranes on
adjacent cells retracted and individual keratinocytes rounded up
(Fig 1a). Immuno¯uorescent confocal microscopy was used to
examine the distribution of the adherens junction proteins E-
cadherin, a-catenin, b-catenin, and plakoglobin. In nontreated
control keratinocytes, staining for E-cadherin, a-catenin, b-
catenin, and plakoglobin was primarily at the cell membrane in
regions of cell±cell contact. For the most part, the staining for these
proteins colocalized (Fig 1a). In contrast, in peroxovanadate-
treated cells, the distribution of adherens junction proteins was
signi®cantly altered: (i) E-cadherin staining at the cell membrane
decreased, whereas punctate cytoplasmic staining increased, similar
to the redistribution of E-cadherin that has been described during
mitosis in Madine±Darby canine kidney cells (Bauer et al, 1998b)
and suggesting partial internalization of E-cadherin; (ii) a-catenin
staining was markedly reduced at the cell membrane without a
compensatory increase in either cytoplasmic or nuclear staining;
(iii) there was decreased b-catenin staining at the cell membrane
and increased cytoplasmic staining of b-catenin; nuclear staining of
b-catenin appeared essentially the same in treated and control
keratinocytes; (iv) there was decreased staining at the cell
membrane and increased cytoplasmic and nuclear staining of
plakoglobin.
The adherens junction complex is disrupted and b-catenin
and plakoglobin are tyrosine phosphorylated in peroxo-
vanadate-treated keratinocytes To further explore the
effects of tyrosine phosphorylation on the redistribution of
adherens junction proteins, we used monoclonal antibodies to
investigate the ability of E-cadherin to coimmunoprecipitate a-
catenin, b-catenin, and plakoglobin in extracts from control and
peroxovanadate-treated keratinocytes. The amount of a-catenin,
b-catenin, and plakoglobin coimmunoprecipitating with E-
cadherin was signi®cantly reduced in E-cadherin immunopre-
cipitates from peroxovanadate-treated cells relative to controls
(Fig 1b). Thus, peroxovanadate treatment was associated with a
decreased ability of the adherens junction proteins a-catenin, b-
catenin, and plakoglobin to form a functional adherens junction
complex with E-cadherin.
Peroxovanadate treatment resulted in tyrosine phosphorylation
of b-catenin and plakoglobin as detected by retarded migration on
SDS-PAGE and by Western blot detection with antiphosphotyr-
osine antibodies; E-cadherin and a-catenin were not detected with
antiphosphotyrosine antibodies from either control or peroxova-
nadate-treated cells (Fig 2). Additionally, in peroxovanadate-
treated cells, the time courses of (i) keratinocyte dyshesion, (ii)
redistribution of b-catenin and plakoglobin, and (iii) tyrosine
phosphorylation of b-catenin and plakoglobin were similar
(Fig 2a±c). These results suggested that tyrosine phosphorylation
of b-catenin and plakoglobin was associated with decreased
keratinocyte cell±cell adhesion and that this dyshesion was
associated with altered subcellular distribution of the adherens
junction proteins.
Tyrosine phosphorylation of b-catenin and plakoglobin
reversibly decreases their binding to E-cadherin and a-
catenin We hypothesized that if tyrosine phosphorylation of b-
catenin or plakoglobin functioned as a biochemical switch to
regulate the association of adherens junction proteins, and if
tyrosine phosphorylation disrupted this association, then removal of
phosphate from tyrosine residues of b-catenin and plakoglobin
should promote reassociation of the adherens junction complexes
(E-cadherin±b-catenin±a-catenin and E-cadherin±plakoglobin±a-
catenin complexes). To investigate this causal relationship, in vitro
reconstitution experiments were performed. Normal human
keratinocytes were grown to 70%±80% con¯uence and incubated
in the presence or absence of peroxovanadate for 60 min prior to
harvesting. Detergent soluble cell extracts were prepared from
control and peroxovanadate-treated cells and subjected to IP with
antibodies to E-cadherin, a-catenin, b-catenin, and plakoglobin.
The immunoprecipitates from peroxovanadate-treated cells were
split into equal fractions; half the sample was treated with PTP and
the other half underwent mock incubation (buffer, but no added
phosphatase). The beads were then washed and exposed to fresh
keratinocyte extracts. Because human keratinocytes have
endogenous tyrosine phosphatase activity (data not shown),
reconstituting mock-incubated samples with control extracts
would result in the addition of phosphatase and thus not differ
signi®cantly from those samples treated with exogenous PTP. To
avoid addition of endogenous phosphatase, peroxovanadate-treated
extracts (in which endogenous tyrosine phosphatase activity is
inhibited) were used to reconstitute the mock-incubated samples;
control extracts were used to reconstitute PTP-treated samples.
After extensive washing, the samples were analyzed by SDS-PAGE
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and Western blot. The results of this experiment are shown in
Fig 3.
From control keratinocytes (i) monoclonal antibodies to E-
cadherin coimmunoprecipitated a-catenin, b-catenin, and plako-
globin (Fig 3a, lane C), (ii) monoclonal antibodies to a-catenin
coimmunoprecipitated E-cadherin, b-catenin, and plakoglobin
(Fig 3b, lane C), (iii) monoclonal antibodies to b-catenin
coimmunoprecipitated E-cadherin and a-catenin, but not plako-
globin (Fig 3c, lane C), and (iv) monoclonal antibodies to
plakoglobin coimmunoprecipitated E-cadherin and a-catenin,
but not b-catenin (Fig 3d, lane C). These data suggest that in
keratinocytes in tissue culture (i) b-catenin binds to E-cadherin and
a-catenin and (ii) plakoglobin similarly binds to E-cadherin and a-
catenin; this re¯ects the core structure of the adherens junction in
these cells.
When E-cadherin, a-catenin, b-catenin, or plakoglobin were
immunoprecipitated from peroxovanadate-treated cells, b-catenin
and plakoglobin were tyrosine phosphorylated; this correlated with
a decrease in the association of (i) b-catenin with a-catenin and E-
cadherin and (ii) plakoglobin with a-catenin and E-cadherin
(Fig 3a±d, lane V). When immunoprecipitated tyrosine phos-
phorylated b-catenin and plakoglobin were treated with the
tyrosine-speci®c phosphatase PTP, and then re-exposed to a-
catenin and E-cadherin present in detergent soluble extracts from
keratinocytes that had not been treated with peroxovanadate,
adherens junction complexes were reconstituted; we observed that
(i) phosphate was removed from both b-catenin and plakoglobin as
evidenced by their increased mobility on SDS-PAGE and by the
loss of reactivity with antiphosphotyrosine antibodies (Fig 3a±d,
lanes V/PTP), and (ii) the E-cadherin±b-catenin±a-catenin
(Fig 3a, b, c, lanes V/PTP) and the E-cadherin±plakoglobin±a-
catenin (Fig 3a, b, d, lanes V/PTP) complexes reformed.
No reassociation of the adherens junction complexes was
observed with tyrosine phosphorylated b-catenin and plakoglobin.
b-Catenin and plakoglobin immunoprecipitates from peroxovana-
date-treated cells that underwent mock incubations without added
PTP remained tyrosine phosphorylated and failed to signi®cantly
reassociate with E-cadherin and a-catenin (Fig 3c±d, lane V).
Furthermore, when re-exposed to peroxovanadate-treated extracts,
neither immunoprecipitated E-cadherin (Fig 3a, lane V) nor a-
catenin (Fig 3b, lane V) substantially reformed adherens junction
complexes because both b-catenin and plakoglobin, in the added
back extracts from peroxovanadate-treated cells, are tyrosine
Figure 1. Peroxovanadate-induced changes in keratinocyte cell±
cell adhesion and adherens junctions. (a) Exposure of keratinocytes
to peroxovanadate results in decreased cell±cell adhesion and a
redistribution of adherens junction proteins. Keratinocytes incubated in
the presence (column V) or absence (column Control) of the tyrosine
phosphatase inhibitor peroxovanadate were ®xed and stained with
monoclonal antibodies to E-cadherin (row E-cad), a-catenin (row a-cat),
b-catenin (row b-cat), and plakoglobin (row Plak), followed by rhodamine
(E-cad, b-cat, and Plak) or FITC (a-cat) conjugated secondary
antibodies, and then examined by confocal laser microscopy. The cell
membranes of control keratinocytes are adjacent to one another and the
predominant staining pattern for each adherens junction protein is cell
membrane. In contrast, the cell membranes of peroxovanadate-treated
keratinocytes are retracted from one another consistent with decreased
cell±cell adhesion. In peroxovanadate-treated cells, there is a reduction in
membrane staining for E-cadherin, a-catenin, b-catenin, and
plakoglobin, with a compensatory increase in cytoplasmic staining for E-
cadherin, b-catenin, and plakoglobin. In treated cells, the overall signal
for a-catenin is markedly reduced. Interestingly, after peroxovanadate
treatment, there is an increase in the nuclear signal from plakoglobin
suggesting that plakoglobin released from the membrane by tyrosine
phosphorylation may translocate to the nucleus. (b) Decreased association
of E-cadherin with a-catenin, b-catenin, and plakoglobin is observed
when E-cadherin is immunoprecipitated from peroxovanadate-treated
keratinocytes. E-cadherin immunoprecipitates from control (C) or
peroxovanadate (V) treated keratinocytes were separated by SDS-PAGE
and analyzed by Western blot by sequential probing of the membrane
using monoclonal antibodies to E-cadherin (E-cad), a-catenin (a-cat),
b-catenin (b-cat), and plakoglobin (Plak). After peroxovanadate
treatment, there is a marked reduction in the ability of E-cadherin to
coimmunoprecipitate a-catenin, b-catenin, and plakoglobin.
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phosphorylated and thus have markedly diminished E-cadherin and
a-catenin binding.
The observed reassociation of adherens junction proteins is
not due to the binding of adherens junction complexes in
the added back extracts to unsaturated antibody If free E-
cadherin, a-catenin, b-catenin, or plakoglobin antibody binding
sites were present after the initial IP, i.e., the antibody was not
saturated, then antigen present in the fresh extracts would bind to
unoccupied antibody binding sites. In this assay, binding of E-
cadherin±b-catenin±a-catenin or E-cadherin±plakoglobin±a-
catenin complexes in the added back extract to unoccupied
antibody would result in increased detection of E-cadherin and a-
catenin and would yield similar results to true reconstitution of the
adherens junction complex. To demonstrate that the conditions
used for IP resulted in saturation of protein G bound antibody by
antigen (E-cadherin, a-catenin, b-catenin, or plakoglobin), E-
cadherin, a-catenin, b-catenin, or plakoglobin immunoprecipitates
were split into equal fractions. One half of each respective IP
reaction was then re-incubated with fresh keratinocyte extracts
under conditions mimicking the reconstitution experiments,
separated by SDS-PAGE, and analyzed by Western blot detection
using the respective antibody. If after the initial IP the antibody was
not saturated, then antigen present in the fresh extracts would bind
to unoccupied antibody resulting in more E-cadherin, a-catenin,
b-catenin, or plakoglobin being detected in the IP reactions that
had undergone re-incubation with fresh extracts. The same amount
of E-cadherin, a-catenin, b-catenin, and plakoglobin was detected
whether or not the initial IP had undergone re-incubation with
fresh extracts (Fig 4a), demonstrating that antibody was saturated
under the conditions used for the initial IP. Thus, the appearance of
E-cadherin±b-catenin±a-catenin and E-cadherin±plakoglobin±a-
catenin complexes in the reconstituted samples was not due to the
binding of adherens junction complexes to unsaturated binding
sites on the protein G bound antibodies.
The observed reassociation of adherens junction complexes
is not due to antigen exchange The displacement of antibody
bound non-E-cadherin±a-catenin associated b-catenin and
plakoglobin by E-cadherin±a-catenin associated b-catenin and
plakoglobin from the added back extract would also mimic
reconstitution. Therefore, it was necessary to demonstrate that
antigen in the added back extracts was not displacing bound antigen
in the initial IP. Tyrosine phosphorylated b-catenin and
plakoglobin from extracts of peroxovanadate-treated extracts
exhibit retarded migration on SDS-PAGE, react with
antiphosphotyrosine antibodies, and can be differentiated from
nontyrosine phosphorylated b-catenin and plakoglobin from
control extracts. This property was used to determine the source
of b-catenin or plakoglobin detected in the immune complex
(extract from initial IP versus added back fresh extract).
b-Catenin and plakoglobin immunoprecipitates from nonper-
oxovanadate-treated keratinocytes were split into equal fractions;
one half was then re-incubated with fresh extracts from
peroxovanadate-treated keratinocytes under conditions mimicking
the reconstitution experiments. Reactions were separated by SDS-
PAGE and analyzed by Western blot detection using b-catenin or
Figure 2. Loss of cell±cell adhesion and
tyrosine phosphorylation of b-catenin and
plakoglobin are rapid changes, occurring
within 15 min of exposure of keratinocytes
to peroxovanadate. (a) Confocal immuno-
¯uorescent micrographs of keratinocytes treated
with peroxovanadate for 0, 15, 30, 45, and
60 min and stained with monoclonal antibodies to
either b-catenin (b-cat) or plakoglobin (Plak).
Peroxovanadate treatment causes (i) a progressive
disruption in cell±cell adhesion, with cell
membranes on adjacent cells retracted and
keratinocytes round up, and (ii) a redistribution of
b-catenin and plakoglobin from the cell
membrane to the cytoplasm and nucleus. (b), (c)
The time course of tyrosine phosphorylation of b-
catenin and plakoglobin immunoprecipitated from
peroxovanadate-treated keratinocytes parallels the
observed decreases in keratinocyte cell±cell
adhesion. b-catenin (b, b-cat IP) and plakoglobin
(c, Plak IP) were immunoprecipitated from
keratinocytes treated with peroxovanadate for 0,
15, 30, 45, and 60 min. IPs were separated by
SDS-PAGE and analyzed by Western blot
detection with monoclonal antibodies to b-
catenin (b-cat), plakoglobin (Plak), and
phosphotyrosine (p-tyr). Tyrosine phosphorylation
of b-catenin and plakoglobin, as detected by
retarded migration in SDS-PAGE and by reaction
with antiphosphotyrosine antibodies, can be seen
within 15 min of exposure of con¯uent
keratinocytes to peroxovanadate. (d), (e) E-
cadherin and a-catenin are not tyrosine
phosphorylated in control and peroxovanadate-
treated keratinocytes. E-cadherin (d, E-cad IP) and
a-catenin (e, a-cat IP) were immunoprecipitated
from keratinocytes treated with peroxovanadate
for 0 and 60 min. IPs were separated by SDS-
PAGE and analyzed by Western blot detection
with monoclonal antibodies to E-cadherin (E-
cad), a-catenin (a-cat), and phosphotyrosine (p-
tyr).
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plakoglobin antibody. If antigen exchange was occurring, then the
IP reactions that were re-incubated with extracts from peroxova-
nadate-treated keratinocytes should contain an additional band of
retarded mobility corresponding to tyrosine phosphorylated b-
catenin or plakoglobin originating from the peroxovanadate
extracts. No such band was observed demonstrating that, under
the conditions used for the reconstitution experiments, antigen in
the added back extracts was not displacing antibody bound antigen
from the initial IP (Fig 4b). These results indicate that tyrosine
phosphorylation of b-catenin and plakoglobin can reversibly
regulate the formation of E-cadherin±b-catenin±a-catenin and
E-cadherin±plakoglobin±a-catenin complexes.
DISCUSSION
Peroxovanadate caused (i) opposing cell membranes on adjacent
adherent keratinocytes to retract from one another and the cells to
assume a more rounded shape, morphologic changes consistent
with decreased keratinocyte cell±cell adhesion (Volberg et al, 1992),
(ii) a decrease in membrane associated E-cadherin, a-catenin, b-
catenin, and plakoglobin, and a concomitant increase in the
cytoplasmic staining of b-catenin and plakoglobin and in the
nuclear staining of plakoglobin, (iii) tyrosine phosphorylation of b-
catenin and plakoglobin, and (iv) markedly decreased binding of b-
catenin and plakoglobin to E-cadherin and a-catenin. The in vitro
removal of phosphate by PTP treatment of b-catenin and
plakoglobin resulted in the reassociation of b-catenin and
plakoglobin with E-cadherin and a-catenin.
No tyrosine phosphorylation of E-cadherin and a-catenin occurs
when keratinocytes are treated with peroxovanadate; therefore,
both control and peroxovanadate-treated keratinocyte extracts
were used as a source for nontyrosine phosphorylated E-cadherin
and a-catenin. In contrast, extracts prepared from normal human
keratinocytes have endogenous tyrosine phosphatase activity; this
endogenous tyrosine phosphatase activity is inhibited in extracts
prepared from peroxovanadate-treated keratinocytes. The presence
in keratinocyte extracts of endogenous PTP activity necessitated
the reconstitution of PTP and mock-incubated samples with
different extracts. PTP-treated samples were reconstituted with
extracts from control keratinocytes; however, incubating immu-
noprecipitated phosphorylated b-catenin and plakoglobin with
Figure 4. Antibody saturation and antigen exchange controls for
reconstitution experiments. (a) Antibody saturation control. Immune
complexes from keratinocyte extracts (lane 1) are compared with
immune complexes from keratinocyte extracts that had been additionally
incubated with fresh extracts under conditions used for reconstitution
experiments (lane 2). No additional protein is immunoprecipitated when
immune complexes are re-incubated with fresh extracts, indicating that
the conditions used for immunoprecipitation result in antigen saturation
of antibody binding sites. E-cad, E-cadherin IP followed by E-cadherin
IB; a-cat, a-catenin IP followed by a-catenin IP; b-cat, b-catenin IP
followed by b-catenin IB; Plak, plakoglobin IP followed by plakoglobin
IB. (b) Antigen exchange control. SDS-PAGE followed by western blot
detection of immune complexes from non-peroxovanadate-treated
keratinocyte extracts (lane 1) compared with immune complexes from
non-peroxovanadate-treated keratinocyte extracts that had been
additionally incubated with fresh extracts from peroxovanadate-treated
cells (lane 2). b-catenin and plakoglobin immunoprecipitated from
peroxovanadate-treated keratinocytes (lane 3) are shown for comparison.
No additional band of retarded migration is seen in immune complexes
re-incubated with peroxovanadate-treated extracts, indicating that
antigen exchange is not occurring. b-cat, b-catenin IP followed by b-
catenin IB; Plak, plakoglobin IP followed by plakoglobin IB.
Figure 3. Tyrosine phosphorylation of b-catenin and plakoglobin reversibly regulates their association with E-cadherin and a-catenin.
Detergent soluble extracts from keratinocytes treated with (columns V and V/PTP) or without (columns C) peroxovanadate, were immunoprecipitated
with antibodies to E-cadherin (a, E-cad IP), a-catenin (b, a-cat IP), b-catenin (c, b-cat IP), and plakoglobin (d, Plak IP). Peroxovanadate induced
tyrosine phosphorylation of b-catenin and plakoglobin, but not E-cadherin or a-catenin; only the region of the gel corresponding to the migration of
b-catenin and plakoglobin is shown in the phosphotyrosine blots. Tyrosine phosphorylation of b-catenin and plakoglobin decreased their ability to co-
IP with E-cadherin and a-catenin. Peroxovanadate-treated immunoprecipitates were then either treated with protein tyrosine phosphatase and re-
exposed to fresh keratinocyte extracts from control cells (columns V/PTP) or mock incubated with buffer, but no added phosphatase, and re-exposed
to fresh keratinocyte extracts from peroxovanadate-treated cells (columns V). Adherens junction complexes reformed after PTP-treatment (lanes V/
PTP); whereas no signi®cant reassociation wass seen if phosphate was not removed from tyrosine residues of antibody bound b-catenin and plakoglobin
(c, d, lanes V) or if tyrosine-phosphorylated b-catenin and plakoglobin from peroxovanadate-treated extracts were added back to antibody-bound E-
cadherin or a-catenin (a, b, lanes V). Therefore, reconstitution of the adherens junction required tyrosine dephosphorylation of b-catenin and
plakoglobin. Samples were separated by SDS-PAGE, transferred to nitrocellulose, and sequentially probed with antibodies to E-cadherin (rows E-cad),
a-catenin (rows a-cat), b-catenin (rows b-cat), plakoglobin (rows Plak), and phosphotyrosine (rows Py). Blots were stripped and reblocked between
each successive probe.
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control extracts containing endogenous phosphatase would be
analogous to adding exogenous PTP. To control for the presence
or absence of phosphatase activity in the reconstitution experiments
required reconstituting mock-incubated samples with peroxovana-
date-treated extracts (a phosphatase-free source of E-cadherin and
a-catenin). Because keratinocyte extracts, not isolated components,
were used to reconstitute adherens junction complexes and because
of the necessity to reconstitute PTP- and mock-incubated samples
with different extracts, we investigated if other events might
explain the observed reassociation of b-catenin/plakoglobin with
E-cadherin and a-catenin. Controls demonstrated that neither
binding of adherens junction complexes in the added back extracts
to unsaturated antibody nor antigen exchange were occurring.
Although not de®nitive, the results are strongly suggestive of a
mechanism by which tyrosine phosphorylation of b-catenin and
plakoglobin disrupts cell±cell adhesion by causing the dissociation
of the E-cadherin±b-catenin±a-catenin and E-cadherin±plakoglo-
bin±a-catenin complexes. Taken together, these observations
support a causal role for tyrosine phosphorylation of b-catenin
and plakoglobin in regulating keratinocyte cell±cell adhesion and
adherens junction function.
The ability to detect a small amount of tyrosine phosphorylated
b-catenin and plakoglobin that could still associate with either E-
cadherin or a-catenin after peroxovanadate treatment may be due
to phosphorylation of additional tyrosine residues in b-catenin and
plakoglobin that are not involved in regulating the association of
the adherens junction proteins. Alternatively, it may be that the
association of b-catenin/plakoglobin with E-cadherin and a-
catenin is regulated by the phosphorylation of not one, but at least
two, tyrosine residues. Phosphorylation of one tyrosine residue
might regulate the interaction of b-catenin/plakoglobin with a-
catenin and phosphorylation of a second tyrosine residue might
regulate the interaction of b-catenin/plakoglobin with E-cadherin.
This would explain our ability to capture tyrosine phosphorylated
(i) b-catenin±E-cadherin, (ii) b-catenin±a-catenin, (iii) plakoglo-
bin±E-cadherin, and (iv) plakoglobin±a-catenin intermediates.
A mechanism by which two separate tyrosine phosphorylation
events regulate the association of (i) b-catenin/plakoglobin with E-
cadherin and (ii) b-catenin/plakoglobin with a-catenin is sup-
ported by the observations of other investigators. Under varying
experimental conditions, some have observed a tyrosine phos-
phorylation associated disruption of the E-cadherin±b-catenin
complex from either a-catenin (Takahashi et al, 1997; Ozawa
and Kemler, 1998) or the a-catenin-related protein vinculin
(Hazan and Norton, 1998), whereas others have observed disrup-
tion of b-catenin (Kinch et al, 1995; Balsamo et al, 1996) or
plakoglobin from cadherin subsequent to tyrosine phosphorylation.
Roura and coworkers demonstrated decreased in vitro binding of
pp60c±src tyrosine-phosphorylated recombinant b-catenin to the
cytoplasmic domain of E-cadherin (Roura et al, 1999). The pp60c±
src modi®ed residues in b-catenin were tyr-86 and tyr-654.
Interestingly, the major site of phosphorylation, tyr-86, had no
effect on E-cadherin binding, whereas their data suggest that
phosphorylation of the minor phosphorylation site at tyr-654
decreased the binding of b-catenin to E-cadherin (Roura et al,
1999). a-Catenin binds to the amino terminus of b-catenin (Aberle
et al, 1994) and it may be that phosphorylation of tyr-86 of b-
catenin, in proximity to the a-catenin binding site, decreases b-
catenin's binding to a-catenin.
A model in which two separate residues regulate the association
of either E-cadherin or a-catenin with b-catenin/plakoglobin
would be consistent with our data and the above-cited studies
(Fig 5). In this model, phosphorylation of an N-terminal tyrosine
residue of b-catenin or plakoglobin decreases the binding to a-
catenin but not E-cadherin, whereas phosphorylation of a tyrosine
residue within the Arm repeat region of b-catenin or plakoglobin
decreases the binding to E-cadherin but not a-catenin. The same
or different tyrosine kinases may be responsible for each phos-
phorylation event.
Increased kinase activity and decreased phosphatase activity are
two in vivo mechanisms that may regulate the adherens junction
function of b-catenin and plakoglobin. Several tyrosine kinases are
candidates for regulating the association of b-catenin and
plakoglobin with E-cadherin and a-catenin. Tyrosine phosphoryl-
ation by src family kinases may regulate the binding of b-catenin/
plakoglobin to E-cadherin (Behrens et al, 1993; Roura et al, 1999),
whereas EGF receptor tyrosine phosphorylation of b-catenin and
plakoglobin may mediate the dissociation of a-catenin from the E-
cadherin±b-catenin±a-catenin and the E-cadherin±plakoglobin±a-
cateinin adherens junction complexes (Hoschuetzky et al, 1994;
Takahashi et al, 1997; Hazan and Norton, 1998). Other kinases,
such as the cytoplasmic tyrosine kinase Tyk2, may also regulate b-
Figure 5. A model for the reversible
regulation by tyrosine phosphorylation of
adherens junction protein binding. Two
separate tyrosine phosphorylation events are
proposed to regulate the binding of b-catenin (or
plakoglobin) to E-cadherin and a-catenin. In
reactions 1 and 4, phosphorylation of a tyrosine
residue in the amino terminus of b-catenin,
perhaps mediated by EGF receptor or related
tyrosine kinases, disrupts b-catenin±a-catenin
binding, whereas in reactions 2 and 3,
phosphorylation of a different tyrosine residue in
the Armadillo repeat region of b-catenin, perhaps
mediated by src family kinases, disrupts b-catenin±
E-cadherin binding. Because each reaction is
reversible, tyrosine phosphorylation of the
adherens junction proteins b-catenin and
plakoglobin represents one possible mechanism by
which cells can dynamically regulate their ability
to adhere to one another.
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catenin (Ruff et al, 1997). Additionally, several phosphatases have
been reported to associate with adherens junctions and may also
have a role in regulating adherens junction structure by a
mechanism in which they maintain b-catenin and plakoglobin in
a dephosphorylated state; these include (i) a member of the
leukocyte antigen related protein tyrosine phosphatase family
(Kypta et al, 1996; Muller et al, 1999), (ii) the receptor PTP m
(Brady-Kalnay et al, 1995; Brady-Kalnay et al, 1998), (iii) the
receptor PTP k (Fuchs et al, 1996), and (iv) the receptor PTP l
(Cheng et al, 1997).
b-Catenin, plakoglobin, and the Drosophila homolog Armadillo
are capable of transducing signaling events from the cell surface to
the nucleus (Karnovsky and Klymkowsky, 1995; Behrens et al,
1996; Huber et al, 1996; Molenaar et al, 1996; van de Wetering et
al, 1997). Current models (for reviews, see Cavallo et al, 1997; Ben-
Ze'ev and Geiger, 1998; Willert and Nusse, 1998; Novak and
Dedhar, 1999) suggest that, in the case of human b-catenin,
binding of the secreted morphogen Wnt to the frizzled
transmembrane receptor suppresses the proteosome-mediated deg-
radation of cytoplasmic b-catenin, perhaps by disrupting the ability
of the serine threonine kinase GSK-3, the tumor suppressor protein
APC, and conductin to target b-catenin for ubiquitination and
proteosome-mediated degradation. Consequently, cytoplasmic
levels of b-catenin are increased, driving the formation of a
bipartite transcription factor between b-catenin and the architec-
tural transcription factors TCF or LEF, which then activate
transcription of downstream target genes.
We observed increased nuclear localization of plakoglobin as a
consequence of its dissociation from E-cadherin at the cell
membrane. Because b-catenin and plakoglobin are known to
mediate signaling events, increased nuclear localization of plako-
globin in peroxovanadate-treated keratinocytes suggests the possi-
bility that the release of plakoglobin from the adherens junction is
associated with altered transcriptional activity in the nucleus. As
suggested by our confocal data, events at the cell surface that disrupt
cell±cell adhesion or, more speci®cally, the adherens junction
might result in translocation of plakoglobin to the nucleus. Here,
plakoglobin may directly transduce the signal that ``informs'' the
cell that adhesion has been disrupted. If this is indeed the case, then
this family of proteins (b-catenin, plakoglobin, Armadillo), by
virtue of their ability to function in cell±cell adhesion as well as in
DNA transcription, may serve as a direct link between events at the
cell surface, namely the sensing of cell±cell adhesion versus
dyshesion, and altered cell growth/differentiation. An interesting
question raised by this suggestion is whether all b-catenin/
plakoglobin signaling is equivalent or whether adherens junction
versus Wnt-mediated signaling regulates different transcriptional
events.
Our results suggest a direct and reversible role for tyrosine
phosphorylation of b-catenin and plakoglobin on the association of
the adherens junction complexes formed by E-cadherin, b-catenin
or plakoglobin, and a-catenin. Our data, in the context of the cited
studies, support a model in which at least two tyrosine phos-
phorylation events regulate the association of these complexes. One
disrupts the binding of a-catenin to either b-catenin or
plakoglobin; the second disrupts the binding of E-cadherin to
either b-catenin or plakoglobin. Mapping the residues on b-catenin
and plakoglobin that are modi®ed by phosphorylation will be
important to furthering our understanding of how this post-
translational modi®cation regulates adherens junction mediated
cell±cell adhesion.
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